Cataract Clinical Trial
Official title:
A Three Arm Prospective Clinical Evaluation of Three FDA Approved Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction.
| Verified date | February 2014 |
| Source | Bausch & Lomb Incorporated |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
The objective of this study is to evaluate the efficacy and subject satisfaction with three different FDA approved lenses for adults over 40 years of age who desire a reduction in spectacle dependence.
| Status | Completed |
| Enrollment | 78 |
| Est. completion date | September 2012 |
| Est. primary completion date | June 2012 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 40 Years and older |
| Eligibility |
Inclusion Criteria: - Subjects must have a clinically documented diagnosis of age-related bilateral cataracts that are considered amenable to treatment with standard phacoemulsification cataract extraction. - Subjects must require a spherical lens power from 10.00 D to 33.00 D - Subjects must have the potential for corrected distance visual acuity (CDVA) of 20/32 or better in both eyes, as documented by a Potential Acuity Meter Exclusion Criteria: - Subjects with conditions with increased risk of zonular rupture, such as pseudoexfoliation syndrome. Zonular rupture during cataract surgery may affect postoperative centration, tilt, and stability of the lens. - Subjects who have any active inflammation or edema (swelling) of the cornea, including but not limited to the following: keratitis, keratoconjunctivitis, and keratouveitis. - Subjects with visually significant diabetic retinopathy (proliferative or non-proliferative) which reduces potential acuity to 20/32 or worse. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | Bausch & Lomb, Inc | Aliso Viejo | California |
| Lead Sponsor | Collaborator |
|---|---|
| Bausch & Lomb Incorporated |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Mesopic Monocular Contrast Sensitivity Without Glare 1.5 and 3 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Postoperative visit 3 (2-3 months) | No |
| Primary | Mesopic Monocular Contrast Sensitivity Without Glare 6 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Postoperative visit 3 (2-3 months) | No |
| Primary | Mesopic Monocular Contrast Sensitivity Without Glare 12 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Postoperative visit 3 (2-3 months) | No |
| Primary | Mesopic Monocular Contrast Sensitivity Without Glare 18 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Postoperative visit 3 (2-3 months) | No |
| Primary | Mesopic Monocular Contrast Sensitivity Without Glare 1.5 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Postoperative visit 4 ( 4-6 months) | No |
| Primary | Mesopic Monocular Contrast Sensitivity Without Glare 3 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Postoperative visit 4 ( 4-6 months) | No |
| Primary | Mesopic Monocular Contrast Sensitivity Without Glare 6 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Postoperative visit 4 ( 4-6 months) | No |
| Primary | Mesopic Monocular Contrast Sensitivity Without Glare 12 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Postoperative visit 4 ( 4-6 months) | No |
| Primary | Mesopic Monocular Contrast Sensitivity Without Glare 18 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Postoperative visit 4 ( 4-6 months) | No |
| Secondary | Binocular Mesopic Contrast Sensitivity Without Glare 1.5 & 3 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Binocular Mesopic Contrast Sensitivity Without Glare 6 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Binocular Mesopic Contrast Sensitivity Without Glare 12 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Binocular Mesopic Contrast Sensitivity Without Glare 18 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Binocular Mesopic Contrast Sensitivity Without Glare 1.5, 3, 6 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Binocular Mesopic Contrast Sensitivity Without Glare 12 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Binocular Mesopic Contrast Sensitivity Without Glare 18 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 1.5 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 3 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 6 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 12 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 18 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 1.5 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 3 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 6 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 12 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Mesopic Monocular Contrast Sensitivity With Glare 18 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Mesopic Binocular Contrast Sensitivity With Glare 1.5, 3 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Mesopic Binocular Contrast Sensitivity With Glare 6 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Mesopic Binocular Contrast Sensitivity With Glare 12 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Mesopic Binocular Contrast Sensitivity With Glare 18 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 3 (2-3 months) | No |
| Secondary | Mesopic Binocular Contrast Sensitivity With Glare 1.5, 3 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Mesopic Binocular Contrast Sensitivity With Glare 6 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Mesopic Binocular Contrast Sensitivity With Glare 12 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Mesopic Binocular Contrast Sensitivity With Glare 18 Cycles/Degree | Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity | Visit 4 (4-6 months) | No |
| Secondary | Optical Scatter | Objective scatter index (OSI) was assessed using the Optical Quality Analysis System(OQAS) and summarized as a continuous variable. For this assessment, an OSI score of 1 or less represents good quality vision, 1-2 indicates some degradation but otherwise normal vision, 2-3 significant light scatter possibly requiring treatment, and scores over 4 severely compromised vision requiring intervention. | Visit 3 (2-3 months) | No |
| Secondary | Optical Scatter | Objective scatter index (OSI) was assessed using the Optical Quality Analysis System(OQAS) and summarized as a continuous variable. For this assessment, an OSI score of 1 or less represents good quality vision, 1-2 indicates some degradation but otherwise normal vision, 2-3 significant light scatter possibly requiring treatment, and scores over 4 severely compromised vision requiring intervention. | Visit 4 (4-6 months) | No |
| Secondary | Monocular Halo and Starburst | Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome. | Visit 3 (2-3 months) | No |
| Secondary | Monocular Halo and Starburst | Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome. | Visit 4 (4-6 months) | No |
| Secondary | Binocular Halo and Starburst | Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome. | Visit 3 (2-3 months) | No |
| Secondary | Binocular Halo and Starburst | Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome. | Visit 4 (4-6 months) | No |
| Secondary | Manifest Refraction | Manifest refraction spherical equivalent (MRSE) was calculated as the value of the sphere plus one-half of the value of the cylinder. | Visit 3 (2-3 Months) | No |
| Secondary | Manifest Refraction | Manifest refraction spherical equivalent (MRSE) was calculated as the value of the sphere plus one-half of the value of the cylinder. | Visit 4 (4-6 Months) | No |
| Secondary | Uncorrected Distance Visual Acuity | High Contrast Uncorrected Distance (UCDVA) measured at 32 inches, Intermediate (UCIVA) at 32 inches, and Near Visual Acuity (UCNVA) at 16 inches | Visit 3 (2-3 months) Visit 4 (4-6 months) | No |
| Secondary | Best-corrected Distance Visual Acuity | High Contrast Distance-Corrected Distance,(BCDVA), Intermediate (DCIVA), and Near Visual Acuity (DCNVA) | Visit 3 (2-3 months) Visit 4 (4-6 months) | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
| Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
| Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
| Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
| Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
| Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
| Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
| Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
| Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
| Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
| Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
| Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
| Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
| Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
| Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
| Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
| Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
| Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
| Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
| Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |